[An experimental study on mineral triozide aggregate and calcium hydroxide-based paste applied to direct pulp capping in rat].
OBJECTIVE
To evaluate the volume change of rat root following direct pulp capping with mineral triozide aggregate(MTA) and calcium hydroxide-based paste (Vitapex) .


METHODS
Sixty-four female, 1-month-old Wistar rats were randomly divided into 4 groups, MTA group, Vitapex group, model group and control group, 16 rats in each group. The right maxillary first molar was taken as experimental tooth and control tooth. The exposed pulp was capped separately with MTA and calcium hydroxide after the pulp had been exposed mechanically, while nothing done to the control group. Using micro-CT and three-dimensional reconstruction techniques, the volume change of rat root was evaluated at 1, 2, 4 weeks and 6 weeks after direct pulp capping. The data were analyzed by an way ANOVA analysis followed by a LSD-t test.


RESULTS
The root volume in the MTA group[(1.08 ± 0.07), (1.32 ± 0.18) mm(3)] was significantly smaller than that in the Vitapex group[(1.28 ± 0.16), (1.59 ± 0.18) mm(3)] at 2 and 4 weeks after operation (P < 0.05) . At the sixth week , there was no significant difference between the MTA group [(1.36 ± 0.03) mm(3)] and the Vitapex group[(1.61 ± 0.31) mm(3)] (P > 0.05) . The root volume in the MTA group and Vitapex group was significantly larger than that in the model group [(0.87 ± 0.09), (1.01 ± 0.17) , (1.02 ± 0.25) mm(3)] from the second to sixth week after operation (P < 0.05) .


CONCLUSIONS
MTA and Vitapex can effectively promote root formation and growth and can be used as biological pulp-capping material.
Department of Pediatrics, Stomatological Hospital, Tianjin Medical University, Tianjin 300070, China.
Yan
Y
Zhao
Asari
A
Jin
Ping
P
Gao
Inoue
I
Mitsuko
D017607:Aluminum Compounds / Q000494:pharmacology*; D000818:Animals; D017610:Calcium Compounds / Q000494:pharmacology*; D002126:Calcium Hydroxide / Q000494:pharmacology*; D003782:Dental Pulp / Q000187:drug effects; D003785:Dental Pulp Capping / Q000379:methods*; D004338:Drug Combinations; D005260:Female; D021621:Imaging, Three-Dimensional; D008963:Molar / Q000000981:diagnostic imaging; D010087:Oxides / Q000494:pharmacology*; D057872:Pulp Capping and Pulpectomy Agents / Q000494:pharmacology*; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D012387:Root Canal Filling Materials / Q000494:pharmacology; D017640:Silicates / Q000494:pharmacology*; D012828:Silicones / Q000494:pharmacology*; D014092:Tooth Root / Q000187:drug effects*; D055114:X-Ray Microtomography
D017607:Aluminum Compounds; D017610:Calcium Compounds; D004338:Drug Combinations; D010087:Oxides; D057872:Pulp Capping and Pulpectomy Agents; D012387:Root Canal Filling Materials; D017640:Silicates; D012828:Silicones; C029584:calcium hydroxide, iodoform, silicone oil drug combination; C086631:mineral trioxide aggregate; D002126:Calcium Hydroxide